Michael Salsbury serves as Executive at NeuroBo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael Salsbury has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2025 involved receiving (via award) 28,147 shares valued at $0.
Michael Salsbury currently holds 45,699 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Salsbury has been a net neutral trader of NRBO stock. They have purchased $0 and sold $0 worth of shares.
Michael Salsbury's most recent insider trade was on Jun 30, 2025, when they sold 28,147 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 27, 2023 | NRBO | $0 | Award | 12,500 | $N/A | Discretionary |
| Jul 27, 2023 | NRBO | $0 | Award | 87,500 | $N/A | Discretionary |